Uganda’s QCI to invest $80m in AIDS and anti-malarial drug capacity
Ugandan drugmaker Quality Chemicals Industries (QCI) will invest $80m in manufacturing operations to boost capacity for the production of generic AIDS and malaria drugs.
Archives for February 3, 2011
IRB receives warning letter
The FDA has issued a warning letter to a Californian IRB for failure to have at least five members and a lack of written procedures.
Big pharma more open to strong relationships, less heavy handed
Big pharma has taken a less heavy handed approach to relationships as cutbacks have made outsourcing key, according to Stephen Munk, CEO of Ash Stevens.
Appointments at Charles River, AMRI and Synexus – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Charles River, AMRI and Synexus.
Lab Research signs LOI with US buyer
Lab Research has signed a non-binding letter of intent (LOI) with a US private equity group interested in acquiring the preclinical contract research organisation (CRO).
Sigma buys pharma standards firm RTC
Sigma-Aldrich has acquired analytical standards and certified reference materials manufacturer Resource Technology Corporation (RTC) to expand its analytical
Cali bioproduction set to grow but education must improve
Californian bioproduction expansions could create jobs in 2011 but changes to education are needed to sustain growth, according to a survey.